Skip to main content
Top

Hepatology International

Issue 3/2019

Content (13 Articles)

Melanoma Review Article

Liver damage related to immune checkpoint inhibitors

Naoshi Nishida, Masatoshi Kudo

Open Access Hepatitis B Original Article

Long-term efficacy and safety of tenofovir disoproxil fumarate in Chinese patients with chronic hepatitis B: 5-year results

Xieer Liang, Zhiliang Gao, Qing Xie, Jiming Zhang, Jifang Sheng, Jun Cheng, Chengwei Chen, Qing Mao, Wei Zhao, Hong Ren, Deming Tan, Junqi Niu, Shijun Chen, Chen Pan, Hong Tang, Hao Wang, Yimin Mao, Jidong Jia, Qin Ning, Min Xu, Shanming Wu, Jun Li, Xinxin Zhang, Wenyan Zhang, Cui Xiong, Jinlin Hou

Immunological recovery in T-cell activation after sustained virologic response among HIV positive and HIV negative chronic Hepatitis C patients

Benjamin Emmanuel, Samer S. El-Kamary, Laurence S. Magder, Kristen A. Stafford, Man E. Charurat, Bhawna Poonia, Cheryl Chairez, Mary McLaughlin, Colleen Hadigan, Henry Masur, Shyam Kottilil

C1QTNF1-AS1 regulates the occurrence and development of hepatocellular carcinoma by regulating miR-221-3p/SOCS3

Hang Li, Bo Zhang, Meng Ding, Shang Lu, Hui Zhou, Dajun Sun, Gang Wu, Xianfeng Gan

Antiviral Agents Original Article

Direct-acting antiviral agents do not increase the incidence of hepatocellular carcinoma development: a prospective, multicenter study

Tatsuya Ide, Hironori Koga, Masahito Nakano, Satoru Hashimoto, Hiroshi Yatsuhashi, Nobito Higuchi, Makoto Nakamuta, Satoshi Oeda, Yuichiro Eguchi, Satoshi Shakado, Shotaro Sakisaka, Yoko Yoshimaru, Yutaka Sasaki, Yuichi Honma, Masaru Harada, Masataka Seike, Tatsuji Maeshiro, Satoshi Miuma, Kazuhiko Nakao, Seiichi Mawatari, Akio Ido, Kenji Nagata, Shuichi Matsumoto, Yuko Takami, Tetsuo Sohda, Tatsuyuki Kakuma, Takuji Torimura

Original Article

The effects of curcumin on the metabolic parameters of non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials

Zhongcao Wei, Na Liu, Xinxing Tantai, Xin Xing, Cailan Xiao, Lirong Chen, Jinhai Wang

Original Article

Lean non-alcoholic fatty liver disease (lean NAFLD): characteristics, metabolic outcomes and risk factors from a 7-year prospective, community cohort study from Sri Lanka

Madunil Anuk Niriella, A. Kasturiratne, A. Pathmeswaran, S. T. De Silva, K. R. Perera, S. K. C. E. Subasinghe, S. K. Kodisinghe, T. A. C. L. Piyaratna, K. Vithiya, A. S. Dassanayaka, A. P. De Silva, A. R. Wickramasinghe, F. Takeuchi, N. Kato, H. J. de Silva

Ultrasound Original Article

Bi-lobar liver biopsy via EUS enhances the assessment of disease severity in patients with non-alcoholic steatohepatitis

Sandeep Khurana, Waseem Butt, Harshit S. Khara, Amitpal S. Johal, Sara F. West, Zong-Ming E. Chen, Andrea L. Berger, David L. Diehl

Hepatic Encephalopathy Original Article

AARC-ACLF score: best predictor of outcome in children and adolescents with decompensated Wilson disease

Seema Alam, Bikrant Bihari Lal, Vikrant Sood, Rajeev Khanna, Guresh Kumar

Hepatitis Original Article

A proposed pathologic sub-classification of drug-induced liver injury

Tailing Wang, Xinyan Zhao, Chen Shao, Lihong Ye, Jing Guo, Na Peng, Honglei Zhang, Jian Li, Yuanyuan Kong, Hong You, Jidong Jia

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.